Literature DB >> 33502456

Treatment of Grover Disease With Dupilumab.

Daniel C Butler1, Alexander Kollhoff2, Tim Berger1.   

Abstract

Year:  2021        PMID: 33502456     DOI: 10.1001/jamadermatol.2020.5097

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

1.  A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective?

Authors:  Francesca Barei; Sara Torretta; Nicole Morini; Silvia Ferrucci
Journal:  Dermatol Ther       Date:  2022-03-22       Impact factor: 3.858

2.  Exacerbation of Galli-Galli Disease Following Dialysis Treatment: A Case Report and Review of Aggravating Factors.

Authors:  Tejas P Joshi; Sally Shaver; Jaime Tschen
Journal:  Cureus       Date:  2021-06-02

3.  Can't handle the itch? Refractory immunotherapy-related transient acantholytic dermatosis: prompt resolution with dupilumab.

Authors:  Eva Shelton; Coley Doolittle; Michi M Shinohara; John A Thompson; Ata S Moshiri
Journal:  JAAD Case Rep       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.